Mastodon

Zinc Paste Instructions for Use

ATC Code

D02AB (Zinc preparations)

Active Substance

Zinc oxide (Ph.Eur. European Pharmacopoeia)

Clinical-Pharmacological Group

Drug with astringent and drying action for external use

Pharmacotherapeutic Group

Preparations with emollient and protective action. Zinc preparations

Pharmacological Action

Zinc oxide exerts a drying, adsorbent, astringent, and disinfectant action.

It reduces exudation and weeping, which alleviates local inflammatory phenomena and irritation.

Indications

Diaper rash, intertrigo, miliaria, dermatitis, ulcerative skin lesions, superficial wounds, and burns.

ICD codes

ICD-10 code Indication
L20.8 Other atopic dermatitis (neurodermatitis, eczema)
L22 Diaper dermatitis
L23 Allergic contact dermatitis
L24 Irritant contact dermatitis
L25 Unspecified contact dermatitis
L30.0 Nummular eczema
L30.4 Erythematous intertrigo
L30.9 Dermatitis, unspecified
L74.3 Unspecified miliaria
L89 Decubitus ulcer and pressure area
L98.4 Chronic skin ulcer, not elsewhere classified
T14.0 Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect)
T30 Burns and corrosions of unspecified body region
ICD-11 code Indication
9A06.70 Atopic eczema of the eyelids
EA40 Tropical phagedenic ulcer
EA80.0 Infantile atopic eczema
EA80.1 Childhood atopic eczema
EA80.2 Adult atopic eczema
EA80.Z Atopic eczema, unspecified
EA82 Nummular dermatitis
EA85.20 Atopic hand eczema
EA85.2Z Hand dermatitis, unspecified
EA85.3 Foot dermatitis
EA89 Generalized eczematous dermatitis of unspecified type
EA8Z Dermatitis or eczema, unspecified
EF60 Ischemic ulceration of the skin
EH40.10 Diaper dermatitis
EH90.Z Pressure ulcer of unspecified degree
EH92 Dermatoses provoked by friction or mechanical impact
EH92.1 Blister due to friction
EK00.Z Allergic contact dermatitis, unspecified
EK02.20 Intertriginous dermatitis due to friction, sweating or contact with body fluids
EK02.Z Irritant contact dermatitis, unspecified
EK5Y Other specified skin lesions provoked by exposure to external factors
EM0Z Unspecified skin disorder
ME60.2 Ulcerative skin lesion of unspecified nature
ND56.0 Superficial injury of unspecified body region
NE11 Burn of unspecified body region

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Apply the paste externally to the affected skin areas.

Administer the paste three to six times daily or as directed by a physician.

Adjust the amount of paste applied according to the size and severity of the lesion.

Apply a thin, uniform layer to completely cover the affected area.

For weeping or exudative lesions, apply the paste more generously to achieve a protective barrier.

Use the paste under an occlusive dressing, gauze bandage, or diaper as required.

Prior to application, ensure the skin is clean and dry.

Gently remove any residual paste and reapply with each dressing change.

For chronic ulcers or pressure sores, apply the paste after proper wound cleansing and debridement.

Discontinue use and consult a physician if irritation, redness, or worsening of the condition occurs.

The duration of therapy is determined by the clinical response and the nature of the skin condition.

Adverse Reactions

Allergic reactions possible skin itching, hyperemia, skin rash.

Contraindications

Hypersensitivity to zinc oxide.

Use in Pregnancy and Lactation

Use during pregnancy and breastfeeding is possible according to indications, in recommended doses.

Pediatric Use

Use in children is possible according to indications, in recommended doses and dosage forms.

Special Precautions

It is not recommended to use zinc oxide preparations in acute purulent-inflammatory diseases.

Avoid contact with the eyes.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Moscow Pharmaceutical Factory CJS (Russia)

Dosage Form

Bottle OTC Icon Zinc paste 25% paste for external use: 25 g jars, 30 g tubes

Dosage Form, Packaging, and Composition

Paste for external use 25% 100 g
Zinc oxide 25 g

25 g – dark glass jars (1) – paper packs.
25 g – dark glass jars.
30 g – aluminum tubes (1) – paper packs.

Marketing Authorization Holder

Tver Pharmaceutical Factory, PJSC (Russia)

Dosage Form

Bottle OTC Icon Zinc paste 25% paste for external use: 20 g, 25 g, 30 g or 40 g tubes 1 pc.; 25 g or 40 g jars 1 pc.

Dosage Form, Packaging, and Composition

Paste for external use white or white with a yellowish tint.

100 g
Zinc oxide 25 g

Excipients : potato starch – 25 g, petrolatum – up to 100 g.

20 g – aluminum tubes (1) – cardboard packs.
25 g – aluminum tubes (1) – cardboard packs.
30 g – aluminum tubes (1) – cardboard packs.
40 g – aluminum tubes (1) – cardboard packs.
25 g – dark glass jars (1) – cardboard packs.
40 g – dark glass jars (1) – cardboard packs.
40 g – polyethylene terephthalate jars (1) – cardboard packs.

Marketing Authorization Holder

Tula Pharmaceutical Factory, LLC (Russia)

Dosage Form

Bottle OTC Icon Zinc paste 25% paste for external use: 25 g jars or tubes

Dosage Form, Packaging, and Composition

Paste for external use 25% 100 g
Zinc oxide 25 g

25 g – dark glass jars (1) – cardboard packs.
25 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Tula Pharmaceutical Factory, LLC (Russia)

Dosage Form

Bottle OTC Icon Zinc paste 250 mg/1 ml paste for external use: jars or tubes

Dosage Form, Packaging, and Composition

Paste for external use 1 ml 1 package
Zinc oxide 250 mg 25 g

25 g – dark glass jars (1) – cardboard packs.
25 g – aluminum tubes (1) – cardboard packs.

Marketing Authorization Holder

Usolye-Sibirskiy Chemical and Pharmaceutical Plant, JSC (Russia)

Dosage Form

Bottle OTC Icon Zinc paste 25% paste for external use: 15 g, 20 g, 25 g or 30 g jars, 25 g or 30 g tubes

Dosage Form, Packaging, and Composition

Paste for external use from white to white with a yellowish tint.

100 g
Zinc oxide 25 g

Excipients : potato starch – 25 g, petrolatum – 50 g.

15 g – jars – cardboard packs.
20 g – jars – cardboard packs.
25 g – jars – cardboard packs.
30 g – jars – cardboard packs.
25 g – tubes – cardboard packs.
30 g – tubes – cardboard packs.

Table of Contents

→ TABLE OF CONTENTS